drugset / Trial / NCT07142161
A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RD13-02 in patients with aT1DM
Timeline
- Start
- 2025-07-20
- Primary completion
- 2026-07-24
- Completion
- 2026-12-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RD13-02 | Cell therapy | — | Intravenous |